Senior AbbVie liaison quits job to launch neuro startup, with sights set on ALS
About a year ago, Howard Berman was sitting in a waiting room at Houston Methodist Hospital with his father, who was showing cognitive loss. They were there to see Joseph Masdeu, one of the leading neurologists in the area.
“You know what?” Berman recalls Masdeu saying. “Why don’t you meet with Dr. Stan Appel, he’s working on some very innovative work in the field of neurodegenerative disease.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.